Clinical Trials Browser

Not yet recruiting × Immunoglobulin Light-chain Amyloidosis × 90 days × Clear all

NCT07624760 2026-06-03

MGUS-PET

Phase NA Not yet recruiting

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

NCT07615270 2026-05-29

A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement

Phase EARLY_PHASE1 Not yet recruiting

Immunoglobulin Light-chain Amyloidosis

NCT07524634 2026-04-24

Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

Phase 2 Not yet recruiting

Immunoglobulin Light-chain Amyloidosis

NCT06971848 2026-03-30

ETCABIO

Phase NA Not yet recruiting

GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT07224672 2026-03-17

ALANIS

Phase 2 Not yet recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis